Changes in international normalized ratios after plasma transfusion of varying doses in unique clinical environments

Matthew Warner, Andrew C. Hanson, Timothy J. Weister, Andrew A. Higgins, Nageswar R. Madde, Darrell R. Schroeder, Justin D. Kreuter, Daryl J Kor

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Background: Plasma transfusion is commonly performed for the correction of abnormal coagulation screening tests. The goal of this investigation was to assess the relationship between the dose of plasma administered and changes in coagulation test results in a large and diverse cohort of patients with varying levels of coagulation abnormalities and comorbid disease and in a variety of clinical settings. METHODS: In this single-center historical cohort study, all plasma transfusion episodes in adult patients with abnormal coagulation screening tests were extracted between 2011 and 2015. The primary outcome was the proportion of patients attaining normal posttransfusion international normalized ratio (INR ≤ 1.1) with secondary outcomes including the proportion of patients attaining partial normalization of INR (INR ≤ 1.5) or at least 50% normalization in pretransfusion values with respect to an INR of 1.1. RESULTS: In total, 6779 unique patients received plasma with a median (quartiles) pretransfusion INR of 1.9 (1.6–2.5) and a median transfusion volume of 2 (2–3) units. The majority (85%) of transfusions occurred perioperatively, with 20% of transfusions administered prophylactically before a procedure. The median decrease in INR was 0.4 (0.2–0.8). Complete INR normalization was obtained in 12%. Reductions in INR were modest with pretransfusion INR values <3. Patients receiving ≥3 units of plasma were more likely to achieve at least 50% normalization in INR than those receiving ≤2 units (68% vs 60%; P < .001). CONCLUSIONS: Changes in INR after plasma transfusion were modest at typically used clinical doses, particularly in those with less severely deranged baseline coagulation screening tests. Further studies are necessary to assess the relationships between plasma-mediated changes in INR and clinical outcomes.

Original languageEnglish (US)
Pages (from-to)349-357
Number of pages9
JournalAnesthesia and Analgesia
Volume127
Issue number2
DOIs
StatePublished - Jan 1 2018

Fingerprint

International Normalized Ratio
Cohort Studies

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Changes in international normalized ratios after plasma transfusion of varying doses in unique clinical environments. / Warner, Matthew; Hanson, Andrew C.; Weister, Timothy J.; Higgins, Andrew A.; Madde, Nageswar R.; Schroeder, Darrell R.; Kreuter, Justin D.; Kor, Daryl J.

In: Anesthesia and Analgesia, Vol. 127, No. 2, 01.01.2018, p. 349-357.

Research output: Contribution to journalReview article

Warner, Matthew ; Hanson, Andrew C. ; Weister, Timothy J. ; Higgins, Andrew A. ; Madde, Nageswar R. ; Schroeder, Darrell R. ; Kreuter, Justin D. ; Kor, Daryl J. / Changes in international normalized ratios after plasma transfusion of varying doses in unique clinical environments. In: Anesthesia and Analgesia. 2018 ; Vol. 127, No. 2. pp. 349-357.
@article{b9a6c1d439bb4ccc8c4e64031fd4b7a5,
title = "Changes in international normalized ratios after plasma transfusion of varying doses in unique clinical environments",
abstract = "Background: Plasma transfusion is commonly performed for the correction of abnormal coagulation screening tests. The goal of this investigation was to assess the relationship between the dose of plasma administered and changes in coagulation test results in a large and diverse cohort of patients with varying levels of coagulation abnormalities and comorbid disease and in a variety of clinical settings. METHODS: In this single-center historical cohort study, all plasma transfusion episodes in adult patients with abnormal coagulation screening tests were extracted between 2011 and 2015. The primary outcome was the proportion of patients attaining normal posttransfusion international normalized ratio (INR ≤ 1.1) with secondary outcomes including the proportion of patients attaining partial normalization of INR (INR ≤ 1.5) or at least 50{\%} normalization in pretransfusion values with respect to an INR of 1.1. RESULTS: In total, 6779 unique patients received plasma with a median (quartiles) pretransfusion INR of 1.9 (1.6–2.5) and a median transfusion volume of 2 (2–3) units. The majority (85{\%}) of transfusions occurred perioperatively, with 20{\%} of transfusions administered prophylactically before a procedure. The median decrease in INR was 0.4 (0.2–0.8). Complete INR normalization was obtained in 12{\%}. Reductions in INR were modest with pretransfusion INR values <3. Patients receiving ≥3 units of plasma were more likely to achieve at least 50{\%} normalization in INR than those receiving ≤2 units (68{\%} vs 60{\%}; P < .001). CONCLUSIONS: Changes in INR after plasma transfusion were modest at typically used clinical doses, particularly in those with less severely deranged baseline coagulation screening tests. Further studies are necessary to assess the relationships between plasma-mediated changes in INR and clinical outcomes.",
author = "Matthew Warner and Hanson, {Andrew C.} and Weister, {Timothy J.} and Higgins, {Andrew A.} and Madde, {Nageswar R.} and Schroeder, {Darrell R.} and Kreuter, {Justin D.} and Kor, {Daryl J}",
year = "2018",
month = "1",
day = "1",
doi = "10.1213/ANE.0000000000003336",
language = "English (US)",
volume = "127",
pages = "349--357",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Changes in international normalized ratios after plasma transfusion of varying doses in unique clinical environments

AU - Warner, Matthew

AU - Hanson, Andrew C.

AU - Weister, Timothy J.

AU - Higgins, Andrew A.

AU - Madde, Nageswar R.

AU - Schroeder, Darrell R.

AU - Kreuter, Justin D.

AU - Kor, Daryl J

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Plasma transfusion is commonly performed for the correction of abnormal coagulation screening tests. The goal of this investigation was to assess the relationship between the dose of plasma administered and changes in coagulation test results in a large and diverse cohort of patients with varying levels of coagulation abnormalities and comorbid disease and in a variety of clinical settings. METHODS: In this single-center historical cohort study, all plasma transfusion episodes in adult patients with abnormal coagulation screening tests were extracted between 2011 and 2015. The primary outcome was the proportion of patients attaining normal posttransfusion international normalized ratio (INR ≤ 1.1) with secondary outcomes including the proportion of patients attaining partial normalization of INR (INR ≤ 1.5) or at least 50% normalization in pretransfusion values with respect to an INR of 1.1. RESULTS: In total, 6779 unique patients received plasma with a median (quartiles) pretransfusion INR of 1.9 (1.6–2.5) and a median transfusion volume of 2 (2–3) units. The majority (85%) of transfusions occurred perioperatively, with 20% of transfusions administered prophylactically before a procedure. The median decrease in INR was 0.4 (0.2–0.8). Complete INR normalization was obtained in 12%. Reductions in INR were modest with pretransfusion INR values <3. Patients receiving ≥3 units of plasma were more likely to achieve at least 50% normalization in INR than those receiving ≤2 units (68% vs 60%; P < .001). CONCLUSIONS: Changes in INR after plasma transfusion were modest at typically used clinical doses, particularly in those with less severely deranged baseline coagulation screening tests. Further studies are necessary to assess the relationships between plasma-mediated changes in INR and clinical outcomes.

AB - Background: Plasma transfusion is commonly performed for the correction of abnormal coagulation screening tests. The goal of this investigation was to assess the relationship between the dose of plasma administered and changes in coagulation test results in a large and diverse cohort of patients with varying levels of coagulation abnormalities and comorbid disease and in a variety of clinical settings. METHODS: In this single-center historical cohort study, all plasma transfusion episodes in adult patients with abnormal coagulation screening tests were extracted between 2011 and 2015. The primary outcome was the proportion of patients attaining normal posttransfusion international normalized ratio (INR ≤ 1.1) with secondary outcomes including the proportion of patients attaining partial normalization of INR (INR ≤ 1.5) or at least 50% normalization in pretransfusion values with respect to an INR of 1.1. RESULTS: In total, 6779 unique patients received plasma with a median (quartiles) pretransfusion INR of 1.9 (1.6–2.5) and a median transfusion volume of 2 (2–3) units. The majority (85%) of transfusions occurred perioperatively, with 20% of transfusions administered prophylactically before a procedure. The median decrease in INR was 0.4 (0.2–0.8). Complete INR normalization was obtained in 12%. Reductions in INR were modest with pretransfusion INR values <3. Patients receiving ≥3 units of plasma were more likely to achieve at least 50% normalization in INR than those receiving ≤2 units (68% vs 60%; P < .001). CONCLUSIONS: Changes in INR after plasma transfusion were modest at typically used clinical doses, particularly in those with less severely deranged baseline coagulation screening tests. Further studies are necessary to assess the relationships between plasma-mediated changes in INR and clinical outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85056560572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056560572&partnerID=8YFLogxK

U2 - 10.1213/ANE.0000000000003336

DO - 10.1213/ANE.0000000000003336

M3 - Review article

C2 - 29596103

AN - SCOPUS:85056560572

VL - 127

SP - 349

EP - 357

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 2

ER -